Skip to main content

Calibre Scientific Acquires Carl Stuart Group, an Irish Distributor of Laboratory and Analytical Consumables and Equipment

Written by Customer Service on . Posted in Mergers And Acquisitions.

LOS ANGELES, Oct. 25, 2021 (GLOBE NEWSWIRE) — Calibre Scientific is pleased to announce the acquisition of Carl Stuart Group, a laboratory and analytical consumables and equipment distributor with headquarters in Dublin, Ireland. Carl Stuart Group’s addition further enhances Calibre Scientific’s presence in Ireland and the United Kingdom.

Carl Stuart Group is a premier distributor of products focused on instrumentation, equipment, consumables, and a critical provider of services across the chromatography, environmental, research lab, and life science verticals. The Company’s diverse customer base consists of pharmaceutical, healthcare, and medical device markets; university research; government entities; and other industrial end customers. Carl Stuart Group’s product offering, and exceptional after-sales service and support, has earned the trust of customers across these end markets.

With this acquisition, Calibre Scientific further enhances its overall position in the chromatography and laboratory supplies market and adds a leading distribution operation to its presence in Ireland. “Given its excellent reputation in the marketplace, Carl Stuart Group is a trusted partner for customers and manufacturers alike,” said Mike Brownleader, Chief Revenue Officer of Calibre Scientific. “We are excited to partner with their company and look forward to driving growth via new product introductions coupled with robust customer support and service capabilities.”

“I am enthusiastic for the future of Carl Stuart Group under Calibre Scientific,” said Stuart Smith, Founder & Chairman of Carl Stuart Group. “The technical expertise and customer relationships of Carl Stuart Group, combined with the proprietary product portfolio and vast supplier relationships across Calibre Scientific, present exciting opportunities for us to broaden our offering to our current customers while attracting new customers to our growing platform.”

About Calibre Scientific

Calibre Scientific is a diversified global provider of life science reagents, tools, instruments, and other consumables to the lab research, diagnostics, industrial, and biopharmaceutical communities. Calibre Scientific owns a portfolio of 20 life science and diagnostic companies that have an unrivaled ability to address the unique challenges of their respective markets. Our global reach extends to 175 countries, empowering customers all over the world. Headquartered in Los Angeles, California, Calibre Scientific continues to grow, further expanding its product offering and global footprint to laboratories across a wide array of verticals and geographies. 

For more information, visit www.calibrescientific.com, or contact Brice Geoffrion, Director of Business Development, at bgeoffrion@calibrescientific.com, or +1 (310) 651-8285.

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.